Intelligent drug-delivery devices based on micro- and nano-technologies

References

• 1  Donev A, Garcia AL, Alder BJ. Stochastic event-driven molecular dynamics. J. Comput. Phys.227,2644–2665 (2008).
  CASGoogle Scholar
• 2  Kim D, Darve E. High-ionic-strength electroosmotic flows in uncharged hydrophobic nanochannels. J. Col. Int. Sci.330,194–200 (2009).
  Medline CASGoogle Scholar
• 3  Shaqfeh ESG. The dynamics of single-molecule DNA in flow. J. Non-Newt. Fl Mech.130,1–28 (2005).
  CASGoogle Scholar
• 4  Somasi M, Khomami B, Woo NJ, Hur JS, Shaqfeh ESG. Brownian dynamics simulations of bead-rod and bead-spring chains: numerical algorithms and coarse-graining issues. J. Non-Newt. Fl. Mech.108,227–255 (2002).
  CASGoogle Scholar
• 5  Xuan Y, Roetzel W. Conceptions for heat transfer correlation of nanofluids. Int. J. Heat Mass. Trans.43,3701–3707 (2000).
  CASGoogle Scholar
• 6  Arifin DY, Lee LY, Wang CH. Mathematical modeling and simulation of drug release from microspheres: implications to drug-delivery systems. Adv. Drug Del. Rev.58,1274–1325 (2006).
  Medline CASGoogle Scholar
• 7  Garcia E, Kirkham JR, Hatch AV, Hawkins KR, Yager P. Controlled microfluidic reconstitution of functional protein from an anhydrous storage depot. Lab. Chip.4,78–82 (2004).
  Medline CASGoogle Scholar
• 8  Gray V, Kelly G, Xia M, Butler C, Thomas S, Mayock S. The science of USP1 and 2 dissolution: present challenges and future relevance. Pharma. Res.26(6),1289–302 (2009).
  CASGoogle Scholar
• 9  Gross JF, Popel AS. Mathematical models of transport phenomena in normal and neoplastic tissue. In: Tumor Blood Circulation. Peterson HI (Ed.). CRC Press, Boca Raton, FL, USA 169–183 (1979).
  Google Scholar
• 10  Siepmann J, SiepmannF. Mathematical modeling of drug delivery. Int. J. Pharm.364,328–343 (2008).
  Medline CASGoogle Scholar
• 11  Lee MH, Huntington MD, Zhou W, Yang JC, Odom TW. Programmable soft lithography: solvent-assisted nanoscale embossing. Nano Lett.11(2),311–315 (2011).
  Medline CASGoogle Scholar
• 12  Zhang N, Byrne CJ, Browne DJ, Gilchris MD. Towards nano injection molding. Mat. Today.15(5),216–221 (2012).
  CASGoogle Scholar
• 13  Lin HY, Chang CH, Young WB. Experimental and analytical study on filling of nano structures in micro injection molding. Int. Commun. Heat Mass. Trans.37,1477–1485 (2010).
  CASGoogle Scholar
• 14  Fu J, Schoch RB, Stevens AL, Tannenbaum SR, Han J. A patterened isoptropic nanofluidic sieving structure for continuous-flow separation of DNA and protein. Nat. Nanotechnol.2,121–128 (2007).
  Medline CASGoogle Scholar
• 15  Surace R, Trotta G, Bellantone V, Fassi I. The micro injection moulding process for polymeric components manufacturing. New Technologies-Trends, Innovations and Research. Volosencu C (Ed.). In Tech, NY, USA, 77 (2012).
  Google Scholar
• 16  Lee KH, Su YD, Chen SJ, Tseng FG, Lee GB. Microfluidic systems integrated with two-dimensional surface plasmon resonance phase imaging systems for micro array immunoassay. Biosens. Bioelectron.23,466–472 (2007).
  Medline CASGoogle Scholar
• 17  KovacJR, Taff BM, Voldman J. Enabling technologies for image-based cell sorting. Analyt. Chem.79(24), (2007).
  Google Scholar
• 18  Dou YH, Bao N, Xu JJ, Meng F, Chen HY. Separation of proteins on surface-modified poly(dimethylsiloxane) microfluidic devices. Electrophoresis25(17),3024–3031 (2004).
  Medline CASGoogle Scholar
• 19  Paegel BM, Blazej RG, Mathies RA. Microfluidic devices for DNA sequencing: sample preparation and electrophoretic analysis. Curr. Opi. Biotech.14(1),42–50 (2003).
  Medline CASGoogle Scholar
• 20  Lu Y, Chen SC. Micro and nano-fabrication of degradable microdevices for drug delivery. Adv. Drug Del. Revs.56(11),1621–1633 (2004).
  Medline CASGoogle Scholar
• 21  Ikuta K, Yamada A, Niikura F. Real three-dimensional microfabrication for biodegradable polymers: demonstration of high-resolution and biocompatibility for implantable microdevices. Presented at: 26^thAnnual International Conference of the IEEE. CA, USA, 1–5 July 2004.
  Google Scholar
• 22  Frew AJ. What are the ‘ideal’ features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis? Allergy66,15–24 (2011).
  Medline CASGoogle Scholar
• 23  Polat BE, Hart D, Blankschtein D, Langer R. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J. Control. Release152,330–348 (2011).
  Medline CASGoogle Scholar
• 24  Maiq Filho AL, Villaverde AB, Munin E, Aimbire F, Albertini R. Comparative study of the topical application of aloe veragel, therapeutic ultrasound and phonophoresis on the tissue repair in collagenase-induced rat tendinitis. Ultrasound Med. Biol.36(10),1682–1690 (2010).
  MedlineGoogle Scholar
• 25  Tezel A, Paliwal S, Shen Z, Mitragotri S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine23(29),3800–3807 (2005).
  Medline CASGoogle Scholar
• 26  Dahlan A, Alpar H, Stickings P, Sesardic D, Murdan S. Transcutaneous immunization assisted by low-frequency ultrasound. Int. J. Pharm.368(1–2),123–128, (2009).
  Medline CASGoogle Scholar
• 27  Paliwal S, Menon G, Mitragotri S. Low-frequency sonophoresis: ultra structuralbasis for stratum corneum permeability assessed using quantum dots. J. Invest. Dermatol.126(5),1095–1101 (2006).
  Medline CASGoogle Scholar
• 28  Seto J, Polat B, Lopez R, Blankschtein D, Langer R. Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and split-thickness pig and human skin. J. Control. Release145(1),26–32 (2010).
  Medline CASGoogle Scholar
• 29  Lee S, Choi K, Menon G et al. Penetration pathways induced by low-frequency sonophoresiswith physical and chemical enhancers: iron oxide nanoparticles versus lanthanum nitrates. J. Invest. Dermatol.130(4),1063–1072 (2010).
  Medline CASGoogle Scholar
• 30  Lopez R, Seto J, Blankschtein D, Langer R. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials32(3),933–941 (2011).
  Medline CASGoogle Scholar
• 31  Roxhed N, Griss P, Stemme G. Membrane-sealed hollow microneedlesand related administration schemes for transdermal drug delivery. Biomed. Microdevices10,271–279 (2008).
  Medline CASGoogle Scholar
• 32  Mukerjee EV, Collins SD, Isseroff RR, Smith RL. Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens. Acts A: Physical.114(2–3),267–275 (2006).
  Google Scholar
• 33  Hafeli UO, Mikhtari A, Liepmann D. In vivo evaluation of a micro needle-based miniature syringe for intradermal drug delivery. Biomed. Micro. Devices11,943–950 (2009).
  Medline CASGoogle Scholar
• 34  Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang D, Daddona P. Transdermal delivery of desmopress in using a coated micro needle array patch system. J. Control. Release97(3),503–511 (2004).
  Medline CASGoogle Scholar
• 35  Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int. J. Pharm.364(2),227–236 (2008).
  Medline CASGoogle Scholar
• 36  Bratlie KM, York RL, Invernale MA, Langer R, Anderson DG. Materials for diabetes therapeutics. Adv. Healthcare Mater.1,267–284 (2012).
  Medline CASGoogle Scholar
• 37  Buchwald H, Varco RL, Rupp WM et al. Treatment of a Type II diabetic by a totally implantable insulin infusion device. Lancet317(8232),1233–1235 (1981).
  Google Scholar
• 38  Swan EE, Mescher MJ, Sewell WF, Tao SL, Borenstein JT. Inner ear drug delivery for auditory applications. Adv. Drug Del. Revs.60,1583–1599 (2008).
  Medline CASGoogle Scholar
• 39  Salt AN, Plontke SK. Local inner-ear drug delivery and pharmacokinetics. Drug Discov. Today10(19),1299–1306 (2005).
  Medline CASGoogle Scholar
• 40  Pararas EEL, Borkholderb DA, Borenstein JT. Micro systems technologies for drug delivery to the inner ear. Adv. Drug Del. Revs.64(14),1650–1660 (2012).
  Medline CASGoogle Scholar
• 41  Sewell WF, Borenstein JT, Chen Z et al. Development of a microfluidics-based intracochleardrug delivery device Audiol. Neurootol.14,411–422 (2009).
  Medline CASGoogle Scholar
• 42  Li PY, Shih J, Lo R et al. An electrochemical intraocular drug delivery device. Sensor. Actuat. A-Phys.143,41–48 (2008).
  CASGoogle Scholar
• 43  Stevenson CL, Santini JT Jr, Langer R. Reservoir-based drug-delivery systems utilizing micro technology. Adv. Drug Deliv. Rev.64(14),1590–602 (2012).
  Medline CASGoogle Scholar
• 44  Lo R, Kuwahar K, Li PY et al. A passive MEMS drug delivery pump for treatment of ocular diseases. Biomed. Microdevices11,959–970 (2009).
  Medline CASGoogle Scholar
• 45  Pirmoradi FN, Jackson JK, Burt HM, Chaio M. On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device. Lab. Chip.11,2744–2752 (2011).
  Medline CASGoogle Scholar
• 46  Rahimi S, Takahata K. A wireless implantable drug delivery device with hydrogel micro valves controlled by field-frequency tuning. Micro electro mechanical systems (MEMS). Presented at: 2011 IEEE 24th International Conference. Cancun, Mexico, 23–27 January 2011.
  Google Scholar
• 47  Farra R, Sheppard NF Jr, McCabe L et al. First-in-human testing of a wirelessly controlled drug delivery microchip. Sci. Transl. Med.4(122),122ra21 (2012).
  Medline CASGoogle Scholar
• 48  Elman NM, Patta Y, Scott AW, Masi B, Ho Duc HL, Cima MJ. The next generation of drug-delivery micro devices. Clin. Pharmacol. Therap.85,544–547 (2009).
  Medline CASGoogle Scholar
• 49  Elman NM, HoDuc HL, Cima MJ. An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care. Biomed. Microdevices11(3),625–631 (2009).
  Medline CASGoogle Scholar
• 50  Dang W, Davau T, Ying P et al. Effects of GLIADEL^® wafer initial molecular weight on the erosion of wafer and release of BCNU. J. Control. Release42,83–92 (1996).
  CASGoogle Scholar
• 51  Grayson R, Choi IS, Tyler BM et al. Multi-pulse drug delivery from aresorbablepolymeric microchip device. Nat. Mater.2,767–772 (2003).
  Medline CASGoogle Scholar
• 52  Sharma HS, Ali SF, Hussain SM, Schlager JJ, Sharma A. Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol.9(3),5055–5072 (2009).
  Medline CASGoogle Scholar
• 53  Voskerician G, Shive MS, Shawgo RS et al. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials24,1959–1967 (2003).
  Medline CASGoogle Scholar
• 54  Malam Y, Loizidou M, Seifalian A. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends. PharmaSci.30(11),592–599 (2009).
  Medline CASGoogle Scholar
• 55  Olson F, Hunt C, Szoka F, Vail W. Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochimicaet. Biophysica Acta.557(1),9–23 (1979).
  Medline CASGoogle Scholar
• 56  Frederiksen L, Anton K, van Hoogevest P, Keller H, Leuenberger H. Preparation of liposomes encapsulating water-soluble compounds using super critical carbon dioxide. J. Pharma Sci.86(8),921–928 (1997).
  Medline CASGoogle Scholar
• 57  Szoka F Jr, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous pace and high capture by reverse-phase evaporation. Proc. Natl Acad. Sci. USA75(9),4194–4198 (1978).
  Medline CASGoogle Scholar
• 58  Perez-Juste G, Mulvaney J, Liz-Marzan L. Shape controll in gold nanoparticle synthesis. Chem. Soc. Revs.37(9),1783–1791 (2008).
  MedlineGoogle Scholar
• 59  Pissuwan D, Valenzuela S, Cortie M. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotech.24(2),62–67 (2006).
  Medline CASGoogle Scholar
• 60  Lasagna-Reeves C, Gonzalez-Romero D, Barria MA et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Research Com.393(4),649–655 (2010).
  Medline CASGoogle Scholar
• 61  Barichello J. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nano precipitation method. Drug. Develops. Indus. Pharm.25(4),471–476 (1999).
  Medline CASGoogle Scholar
• 62  Damge C, Reis C, Maincent P. Nanoparticle strategies for the oral delivery of insulin. Expert. Opin. Drug Deliv.5(1),45–68 (2008).
  Medline CASGoogle Scholar
• 63  Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switch nanoparticles for bacterial cell wall-targeted delivery of antibiotics ASC Nano6(5),4279–4287 (2012).
  CASGoogle Scholar
• 64  Moore T, Graham E, Mattix B, Alexis F. Nanoparticles to cross biological barriers. In: Biomaterials Science: An Integrated Clinical and Engineering Approach. Rosen Y, Elman N (Eds). 85–121. CRC Press, Boca Raton, FL, USA (2012).
  Google Scholar
• 65  Booth C, Potten CS. Keratinocyte growth factor increases hair follicle survival following cytotoxic insult. J. Invest. Dermatol.114(4),667–673 (2000).
  Medline CASGoogle Scholar
• 66  Köseoglu V, Kürekçi AE, Sorici Ü, Atay AA, Özcan O. Comparison of the efficacy and side-effects of ondansetronand metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antieoplastic chemotherapy: a prospective randomized study. Eur. J. Pediatr.157(10) 806–810 (1998).
  Medline CASGoogle Scholar
• 67  Hughes W. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis.34(6),730–751 (2002).
  MedlineGoogle Scholar
• 68  Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin H, Jorma I. Association of c-erbB-2 protein over- expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int. J. Cancer.49(5),650–655 (1991).
  Medline CASGoogle Scholar
• 69  Lin WL, Kuo WH, Chen FL et al. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-over expressed mucinous epithelial ovarian cancer. Annals. Surg. Oncol.18(8),2388–2394 (2011).
  MedlineGoogle Scholar
• 70  Santin AD, Bellone D, Roman JJ, McKenney JK, Pecorelli S. Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu. Int. J. Gyne. Obstet.102(2),128–131 (2003).
  Google Scholar
• 71  Kono K, Naganuma H, Sekikawa T, Amemiya H, Takahashi A. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue. Tumor Biology J. Int. Soc. Onco. Developmental Bio. Med.3,139–144 (2000).
  Google Scholar
• 72  Hynes N, Stern D. The biology of erbB-2/HER-2 and its role in cancer. Bioch. Biophysica Acta.1198(2–3),165–184 (1994).
  MedlineGoogle Scholar
• 73  Semenza G. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends. Pharma. Sci.33(4),207–214 (2012).
  Medline CASGoogle Scholar
• 74  Cheng J. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials28(5),869–876 (2007).
  Medline CASGoogle Scholar
• 75  Fetal A. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem.3(12),1839–1843 (2008).
  MedlineGoogle Scholar
• 76  Service R. Nanoparticle trojan horses gallop from the lab to the clinic. Science330(6002),314–315 (2010).
  Medline CASGoogle Scholar
• 77  Ghosh A, Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J. Cell. Biochem.91,528–539 (2004).
  Medline CASGoogle Scholar
• 78  Kleinstreuer C, Li J, Koo J. Microfluidics of nano-drug delivery. Int. J. Heat. Mass. Transfer.51(23–24),5590–5597 (2008).
  Google Scholar
• 79  Fiering J, Mescher MJ, Leary Swan EE et al. Local drug delivery with a self-contained, programmable, microfluidic system. Biomedical Microdevices11(3),571–578 (2009).
  Medline CASGoogle Scholar
• 80  Pirmoradi FN, Jackson J, Burt H, Chiao M. Delivery of an anti-cancer drug from a magnetically controlled MEMS device show cytotoxicity in PC3 and HUVEC cells. Presented at: Solid-State Sensors, Actuators and Microsystems Conference, 16th International. Beijing, China, 5–9 June 2011.
  Google Scholar
• 81  Rahimi S, Sarraf EH, Wong GK, Takahata K. Implantable drug delivery device using frequency-controlled wireless hydrogel microvalves. Biomedical Microdevices13(2),267–277 (2011).
  Medline CASGoogle Scholar
• 101  Bang & lufsenMedicom A/S: US0312195 A1 (2008).
  Google Scholar
• 102  Chun T: S0005737 A1 (2007).
  Google Scholar
• 103  Sanofi-Aventis Deutchland GmbH: US0101446 A1 (2012).
  Google Scholar
• 104  Aegis Therapeutics Inc.: US0031549 (2005).
  Google Scholar
• 105  SHL Group AB: US0222742 A1 (2010).
  Google Scholar
• 106  Massachusetts Institute of Technology: US6939323 B2 (2005).
  Google Scholar
• 107  Massachusetts Institute of Technology: US7425204 B2 (2008).
  Google Scholar
• 108  Marpam International, Inc.: US4874367 (1988).
  Google Scholar
• 109  Clark WD, Hollenbeck KE: US3853125 (1974).
  Google Scholar
• 110  SHL Group AB: US0249705 A1 (2010).
  Google Scholar
• 201  Incline therapeutics. http://inclinethera.com/?page_id=74
  Google Scholar
• 202  InterSpace™. www.transpharma-medical.com/ViaDor_system.html
  Google Scholar
• 203  ONdrugDELIVERY. www.ondrugdelivery.com/publications/diabetes.pdf (PassPort)
  Google Scholar
• 204  ONdrugDELIVERY. Niche information and guidance. www.ondrugdelivery.com/publications/diabetes.pdf (general)
  Google Scholar
• 205  Animas insulin pump. www.animas.com/animas-insulin-pumps/onetouch-ping
  Google Scholar
• 206  OmniPod. Insulin management system. www.myomnipod.com
  Google Scholar
• 207  Debiotech. www.debiotech.com
  Google Scholar
• 208  Debiotech. JewelPUMP™. www.JewelPUMP.com
  Google Scholar
• 209  Solo. New possibilities. www.solo4you.com/?page=AboutSolo&ID=9&pageType=0
  Google Scholar
• 210  Pancreum™: the wearable artificial pancreas company. pancreum.com/index.html
  Google Scholar
• 211  Medtronic Diabetes: Paradigm revel pump. www.medtronicdiabetes.com/products/paradigmrevelpump
  Google Scholar
• 212  Replenish Inc. ophthalmic micropump™ system. www.replenishinc.com/our-technology/ophthalmic-micropump-system
  Google Scholar
• 213  On Demand therapeutics: breaking through challenges in ophthalmic drug delivery. www.ondemandtx.com
  Google Scholar
• 214  Martin F. Liposome drug products: product evolution and influence of formulation on pharmaceutical properties and pharmacology (2012). www.fda.gov/ohrms/dockets/ac/01/slides/3763s2_08_martin/sld001.htm
  Google Scholar
• 215  DiabetesBasics. Diabetes Statistics.N.p., July 2012. www.diabetes.org/diabetes-basics/diabetes- statistics/?loc=DropDownDB-stats
  Google Scholar